Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Stent development and local drug delivery.
Regar E, Sianos G, Serruys PW. Regar E, et al. Br Med Bull. 2001;59:227-48. doi: 10.1093/bmb/59.1.227. Br Med Bull. 2001. PMID: 11756213 Review.
Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
Regar E, Serruys PW, Bode C, Holubarsch C, Guermonprez JL, Wijns W, Bartorelli A, Constantini C, Degertekin M, Tanabe K, Disco C, Wuelfert E, Morice MC; RAVEL Study Group. Regar E, et al. Circulation. 2002 Oct 8;106(15):1949-56. doi: 10.1161/01.cir.0000034045.36219.12. Circulation. 2002. PMID: 12370218 Free article. Clinical Trial.
One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents.
Hofma SH, Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, Regar E, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, Van Domburg RT, Serruys PW. Hofma SH, et al. Among authors: regar e. Heart. 2005 Sep;91(9):1176-80. doi: 10.1136/hrt.2005.064519. Epub 2005 May 9. Heart. 2005. PMID: 15883132 Free PMC article.
Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease.
Diletti R, Ishibashi Y, Felix C, Onuma Y, Nakatani S, van Mieghem NM, Regar E, Valgimigli M, de Jaegere PP, van Ditzhuijzen N, Fam JM, Ligthart JMR, Lenzen MJ, Serruys PW, Zijlstra F, Jan van Geuns R. Diletti R, et al. Among authors: regar e. Catheter Cardiovasc Interv. 2017 Jul;90(1):58-69. doi: 10.1002/ccd.26832. Epub 2016 Nov 29. Catheter Cardiovasc Interv. 2017. PMID: 27896897
Value of coronary stenotic flow velocity acceleration on the prediction of long-term improvement in functional status after angioplasty.
Albertal M, Regar E, Piek JJ, Van Langenhove G, Carlier SG, Thury A, Sianos G, Boersma E, de Bruyne B, di Mario C, Serruys PW; Doppler Endpoints Balloon Angioplasty Trial Europe (DEBATE) Study Group. Albertal M, et al. Among authors: regar e. Am Heart J. 2001 Jul;142(1):81-6. doi: 10.1067/mhj.2001.115590. Am Heart J. 2001. PMID: 11431661
Uncomplicated moderate coronary artery dissections after balloon angioplasty: good outcome without stenting.
Albertal M, Van Langenhove G, Regar E, Kay IP, Foley D, Sianos G, Kozuma K, Beijsterveldt T, Carlier SG, Belardi JA, Boersma E, Sousa JE, de Bruyne B, Serruys PW; DEBATE II Study Group. Albertal M, et al. Among authors: regar e. Heart. 2001 Aug;86(2):193-8. doi: 10.1136/heart.86.2.193. Heart. 2001. PMID: 11454840 Free PMC article. Clinical Trial.
355 results